首页 > 最新文献

Journal of clinical nephrology and renal care最新文献

英文 中文
Utility of Trend of Nephrocheck® (IGFBP7 × TIMP-2) Biomarker for Early Identification of Acute Kidney Injury in Critically Ill Patients with Sepsis or Respiratory Failure Nephrocheck®(IGFBP7×TIMP-2)生物标志物在脓毒症或呼吸衰竭危重患者急性肾损伤早期识别中的应用
Pub Date : 2018-12-31 DOI: 10.23937/2572-3286.1510039
Gupta Ena, Sujith Ravi, Sidhu Nimrita, C. M. Martinez, B. Michael, Awsare Bharat
Introduction: Many studies have shown the association between acute kidney injury (AKI) and morbidity and mortality in the Intensive Care Unit (ICU). Traditional measures of AKI, such as serum creatinine and urine output, fail to show dynamic changes in renal function. A feasibility study was performed to evaluate the Nephrocheck® test system which comprises of two biomarkers (Insulin-like growth factor binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2)) to screen for patients at risk for AKI in the ICU and to guide management. Methods: Patients were enrolled between November 2016 and March 2017 with respiratory failure or sepsis with no pre-existing elevation in the creatinine admitted to the ICU. In patients with an initial Nephrocheck® value ≥ 0.3, the primary team was notified and a kidney protective bundle was suggested. A repeat Nephrocheck® test was performed within 24 hours in those patients with initial value ≥ 0.3. Results: Twenty patients were enrolled. Six (30%) patients developed AKI during first week of ICU stay. All six patients had initial Nephrocheck® values ≥ 0.3 that subsequently increased with the second Nephrocheck® test at 24 hours. Seven patients had normal Nephrocheck® values on admission and did not develop AKI. Interestingly, seven patients who had initial Nephrocheck® values ≥ 0.3 that decreased at 24 hours did not develop AKI. Conclusion: The trend of the Nephrocheck® values was more significant than the initial value for the development of AKI. The Nephrocheck® test may be used as an early indicator of development of AKI. However, further studies are needed to determine if nephron-protective interventions can be helpful in mitigating this risk.
引言:许多研究表明,急性肾损伤(AKI)与重症监护室(ICU)的发病率和死亡率之间存在关联。传统的AKI指标,如血清肌酐和尿量,无法显示肾功能的动态变化。进行了一项可行性研究,以评估由两种生物标志物(胰岛素样生长因子结合蛋白7(IGFBP7)和金属蛋白酶组织抑制剂-2(TIMP-2))组成的Nephrocheck®测试系统,以筛查ICU中有AKI风险的患者并指导管理。方法:在2016年11月至2017年3月期间,因呼吸衰竭或败血症入院的患者,其先前没有肌酐升高。在初始Nephrocheck®值≥0.3的患者中,通知主要团队并建议使用肾脏保护束。对于初始值≥0.3的患者,在24小时内进行重复肾检查®测试。结果:20名患者入选。6名(30%)患者在入住ICU的第一周出现AKI。所有6名患者的初始Nephrocheck®值均≥0.3,随后在24小时进行第二次Nephrochell®测试后,该值增加。7名患者入院时Nephrocheck®值正常,未出现AKI。有趣的是,7名初始Nephrocheck®值≥0.3并在24小时内下降的患者没有出现AKI。结论:Nephrocheck®值的趋势对AKI的发展比初始值更显著。Nephrocheck®测试可作为AKI发展的早期指标。然而,还需要进一步的研究来确定肾单位保护性干预措施是否有助于降低这种风险。
{"title":"Utility of Trend of Nephrocheck® (IGFBP7 × TIMP-2) Biomarker for Early Identification of Acute Kidney Injury in Critically Ill Patients with Sepsis or Respiratory Failure","authors":"Gupta Ena, Sujith Ravi, Sidhu Nimrita, C. M. Martinez, B. Michael, Awsare Bharat","doi":"10.23937/2572-3286.1510039","DOIUrl":"https://doi.org/10.23937/2572-3286.1510039","url":null,"abstract":"Introduction: Many studies have shown the association between acute kidney injury (AKI) and morbidity and mortality in the Intensive Care Unit (ICU). Traditional measures of AKI, such as serum creatinine and urine output, fail to show dynamic changes in renal function. A feasibility study was performed to evaluate the Nephrocheck® test system which comprises of two biomarkers (Insulin-like growth factor binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2)) to screen for patients at risk for AKI in the ICU and to guide management. Methods: Patients were enrolled between November 2016 and March 2017 with respiratory failure or sepsis with no pre-existing elevation in the creatinine admitted to the ICU. In patients with an initial Nephrocheck® value ≥ 0.3, the primary team was notified and a kidney protective bundle was suggested. A repeat Nephrocheck® test was performed within 24 hours in those patients with initial value ≥ 0.3. Results: Twenty patients were enrolled. Six (30%) patients developed AKI during first week of ICU stay. All six patients had initial Nephrocheck® values ≥ 0.3 that subsequently increased with the second Nephrocheck® test at 24 hours. Seven patients had normal Nephrocheck® values on admission and did not develop AKI. Interestingly, seven patients who had initial Nephrocheck® values ≥ 0.3 that decreased at 24 hours did not develop AKI. Conclusion: The trend of the Nephrocheck® values was more significant than the initial value for the development of AKI. The Nephrocheck® test may be used as an early indicator of development of AKI. However, further studies are needed to determine if nephron-protective interventions can be helpful in mitigating this risk.","PeriodicalId":73669,"journal":{"name":"Journal of clinical nephrology and renal care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42358453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Deletion of the Lipid Raft Protein Caveolin-1 Leads to Worsening Renal Fibrosis 脂质筏蛋白Caveolin-1基因缺失导致肾纤维化恶化
Pub Date : 2018-12-31 DOI: 10.23937/2572-3286.1510037
Chand S, Hazeldine J, Smith Sw, B. R
Citation: Chand S, Hazeldine J, Smith SW, Borrows R (2018) Genetic Deletion of the Lipid Raft Protein Caveolin-1 Leads to Worsening Renal Fibrosis. J Clin Nephrol Ren Care 4:037. doi.org/10.23937/25723286.1510037 Accepted: June 23, 2018: Published: June 25, 2018 Copyright: © 2018 Chand S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
引用本文:Chand S, Hazeldine J, Smith SW, Borrows R(2018)脂质筏蛋白Caveolin-1基因缺失导致肾纤维化恶化。[J]中华肾脏病杂志,第4期。doi.org/10.23937/25723286.1510037接收日期:2018年6月23日发布日期:2018年6月25日版权所有:©2018 Chand S, et al.。这是一篇根据知识共享署名许可协议发布的开放获取文章,该协议允许在任何媒体上不受限制地使用、分发和复制,前提是要注明原作者和来源。
{"title":"Genetic Deletion of the Lipid Raft Protein Caveolin-1 Leads to Worsening Renal Fibrosis","authors":"Chand S, Hazeldine J, Smith Sw, B. R","doi":"10.23937/2572-3286.1510037","DOIUrl":"https://doi.org/10.23937/2572-3286.1510037","url":null,"abstract":"Citation: Chand S, Hazeldine J, Smith SW, Borrows R (2018) Genetic Deletion of the Lipid Raft Protein Caveolin-1 Leads to Worsening Renal Fibrosis. J Clin Nephrol Ren Care 4:037. doi.org/10.23937/25723286.1510037 Accepted: June 23, 2018: Published: June 25, 2018 Copyright: © 2018 Chand S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":73669,"journal":{"name":"Journal of clinical nephrology and renal care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47309792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Alport Syndrome: No Evidence of Improved Prognosis in Modern Era Alport综合征:现代尚无改善预后的证据
Pub Date : 2018-12-30 DOI: 10.23937/2572-3286.1510036
Y. Kelly, L. Wallis, A. Patil, S. Murray, S. Kant, M. Kaballo, L. Casserly, B. Doyle, T. Dorman, P. O’Kelly, P. Conlon
Citation: Kelly YP, Wallis L, Patil A, Murray S, Kant S, et al. (2018) Alport Syndrome: No Evidence of Improved Prognosis in Modern Era. J Clin Nephrol Ren Care 4:036. doi.org/10.23937/25723286.1510036 Accepted: June 07, 2018: Published: June 09, 2018 Copyright: © 2018 Kelly YP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
引文:Kelly YP,Wallis L,Patil A,Murray S,Kant S,et al.(2018)Alport综合征:现代没有改善预后的证据。临床肾病杂志,任护理4:036。doi.org/10.23937/25723286.1510036接受时间:2018年6月7日:发布时间:2018月9日版权所有:©2018 Kelly YP等人。这是一篇根据知识共享署名许可证条款分发的开放获取文章,该许可证允许在任何媒体中不受限制地使用、分发和复制,前提是原作者和来源可信。
{"title":"Alport Syndrome: No Evidence of Improved Prognosis in Modern Era","authors":"Y. Kelly, L. Wallis, A. Patil, S. Murray, S. Kant, M. Kaballo, L. Casserly, B. Doyle, T. Dorman, P. O’Kelly, P. Conlon","doi":"10.23937/2572-3286.1510036","DOIUrl":"https://doi.org/10.23937/2572-3286.1510036","url":null,"abstract":"Citation: Kelly YP, Wallis L, Patil A, Murray S, Kant S, et al. (2018) Alport Syndrome: No Evidence of Improved Prognosis in Modern Era. J Clin Nephrol Ren Care 4:036. doi.org/10.23937/25723286.1510036 Accepted: June 07, 2018: Published: June 09, 2018 Copyright: © 2018 Kelly YP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":73669,"journal":{"name":"Journal of clinical nephrology and renal care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43256185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Case Report: 52-Year-Old Male with Right Upper Quadrant Abdominal Pain 病例报告:52岁男性右上腹腹痛
Pub Date : 2018-12-20 DOI: 10.23937/2572-3286.1510040
H. Hasnain, N. Afif, S. Nicholas
Renal artery dissections (RADs) are lesions that disrupt vessels that primarily occur in patients with a known history of hypertension and caused by stenosis or enlargement of the renal artery typically due to underlying connective tissue disorders. However, RADs may occur spontaneously from trauma and no previous history of hypertension. Here, we report a rare case of bilateral isolated spontaneous RADs that characteristically occurs in healthy males. A 52-year-old male presented with left lower quadrant abdominal pain and renal insufficiency. Two years prior, he had experienced a similar episode of pain on the contralateral side, which was due to an infarct of the right kidney. On this admission, a computed tomography angiogram confirmed a new infarct of the left kidney, with dissection of a branch of the renal artery supplying the upper lobe. Work-up for cardiovascular, hematologic, radiographic or connective tissue causes was negative. We postulate that both RADs were potentially associated with the rapid twisting and turning of the abdominal area on a daily basis required for his occupation as an air traffic controller. The patient was treated with a renin angiotensin system inhibitor. After one year, both RADs had significantly improved and his renal function increased by ~23%. Isolated RAD may be associated with consistent or long-term activities that require rapid twisting and turning of the abdominal area. If left untreated, this may result in malignant hypertension, bilateral dissections, or renal ischemia. To avoid misdiagnosis; we provide a comprehensive review of the typical presentation and necessary assessment and management.
肾动脉夹层(RADs)是一种破坏血管的病变,主要发生在已知有高血压病史的患者,通常由潜在结缔组织疾病引起的肾动脉狭窄或扩大引起。然而,RADs可能是由外伤和无高血压病史自发发生的。在此,我们报告一例罕见的双侧孤立自发性RADs,其特征发生在健康男性中。男,52岁,左下腹腹痛,肾功能不全。两年前,他曾在对侧经历过类似的疼痛发作,这是由于右肾梗塞。在此入院时,计算机断层血管造影证实新的左肾梗死,并伴有供应肾上叶的肾动脉分支的剥离。心血管、血液学、放射学或结缔组织病因检查均为阴性。我们假设这两种RADs都可能与他作为空中交通管制员的职业所需的每天腹部区域的快速扭转和转动有关。患者接受肾素血管紧张素系统抑制剂治疗。1年后,两组RADs均显著改善,肾功能提高约23%。孤立性RAD可能与持续或长期的活动有关,这些活动需要腹部区域的快速扭转。如果不及时治疗,可能导致恶性高血压、双侧夹层或肾缺血。避免误诊;我们提供了一个全面的审查,典型的表现和必要的评估和管理。
{"title":"Case Report: 52-Year-Old Male with Right Upper Quadrant Abdominal Pain","authors":"H. Hasnain, N. Afif, S. Nicholas","doi":"10.23937/2572-3286.1510040","DOIUrl":"https://doi.org/10.23937/2572-3286.1510040","url":null,"abstract":"Renal artery dissections (RADs) are lesions that disrupt vessels that primarily occur in patients with a known history of hypertension and caused by stenosis or enlargement of the renal artery typically due to underlying connective tissue disorders. However, RADs may occur spontaneously from trauma and no previous history of hypertension. Here, we report a rare case of bilateral isolated spontaneous RADs that characteristically occurs in healthy males. A 52-year-old male presented with left lower quadrant abdominal pain and renal insufficiency. Two years prior, he had experienced a similar episode of pain on the contralateral side, which was due to an infarct of the right kidney. On this admission, a computed tomography angiogram confirmed a new infarct of the left kidney, with dissection of a branch of the renal artery supplying the upper lobe. Work-up for cardiovascular, hematologic, radiographic or connective tissue causes was negative. We postulate that both RADs were potentially associated with the rapid twisting and turning of the abdominal area on a daily basis required for his occupation as an air traffic controller. The patient was treated with a renin angiotensin system inhibitor. After one year, both RADs had significantly improved and his renal function increased by ~23%. Isolated RAD may be associated with consistent or long-term activities that require rapid twisting and turning of the abdominal area. If left untreated, this may result in malignant hypertension, bilateral dissections, or renal ischemia. To avoid misdiagnosis; we provide a comprehensive review of the typical presentation and necessary assessment and management.","PeriodicalId":73669,"journal":{"name":"Journal of clinical nephrology and renal care","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46690444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effects of Intra-Dialysis Resistance Training in Hemodynamic Parameters, Oxidative Stress and Health-Related Quality of Life in Patients with Chronic Kidney Disease 透析阻力训练对慢性肾病患者血流动力学参数、氧化应激和健康相关生活质量的影响
Pub Date : 2018-06-30 DOI: 10.23937/2572-3286.1510035
Lourenço Bruna S, Nascimento Marcos A, Siqueira Vicente N, Draibe Sérgio A, Mello Marco T, Tufik Sérgio, Canziani Maria EF, Higa Elisa MS
Purpose: Chronic kidney disease is a public health problem that causes severe complications to the patient. The major damage is the loss of muscle mass, with a consequent reduction in the functional capacity that is associated with hypertension and increased oxidative stress. This study aimed to evaluate the effect of intra-dialysis resistance training on the hemodynamic parameters, oxidative stress and quality of life in patients with chronic kidney disease. Methods: The volunteers underwent a physical training during the hemodialysis sessions. The hemodynamic parameters, oxidative stress, the quality of life, the functional autonomy and one repetition maximum (1 RM) were evaluated. Results: The data did not show alterations in the hemodynamic parameters, nitric oxide or lipid peroxidation after 12 weeks of resistance training. We observed significant differences in the quality of life in the following dimensions of the Kidney Disease Quality of Life Short Form (KDQOL-SFTM) questionnaire after 12 weeks of resistance training: Functional capacity, physical aspects, vitality, social and emotional aspects and mental health (P < 0.05). The time needed to execute the functional autonomy test was improved after the resistance training, and strength was increased significantly in all the exercises, as assessed by the 1 RM test (P < 0.001). Conclusion: In conclusion, after 12 weeks, the intra-dialysis resistance training did not modify the hemodynamic parameters neither the oxidative stress profile of these patients, but improved their quality of life. These data show that intra-dialysis resistance training is safe and can provide many physical and emotional benefits to chronic kidney disease patients.
目的:慢性肾脏疾病是一种公共卫生问题,会给患者带来严重的并发症。主要的损害是肌肉量的减少,随之而来的是与高血压和氧化应激增加有关的功能能力的降低。本研究旨在评价透析内阻力训练对慢性肾病患者血流动力学参数、氧化应激及生活质量的影响。方法:志愿者在血液透析期间进行体能训练。评估两组患者血流动力学参数、氧化应激、生活质量、功能自主性和一次重复最大值(1 RM)。结果:数据显示12周阻力训练后血液动力学参数、一氧化氮或脂质过氧化没有改变。我们观察到,经过12周阻力训练后,肾脏疾病生活质量短表(KDQOL-SFTM)问卷的以下维度:功能能力、身体方面、活力、社会和情感方面以及心理健康方面的生活质量存在显著差异(P < 0.05)。阻力训练后进行功能自主测试所需的时间有所改善,通过1 RM检验,所有练习的力量都显著增加(P < 0.001)。结论:在透析12周后,透析阻力训练没有改变患者的血液动力学参数和氧化应激谱,但改善了患者的生活质量。这些数据表明,透析内阻力训练是安全的,可以为慢性肾病患者提供许多身体和情感上的益处。
{"title":"Effects of Intra-Dialysis Resistance Training in Hemodynamic Parameters, Oxidative Stress and Health-Related Quality of Life in Patients with Chronic Kidney Disease","authors":"Lourenço Bruna S, Nascimento Marcos A, Siqueira Vicente N, Draibe Sérgio A, Mello Marco T, Tufik Sérgio, Canziani Maria EF, Higa Elisa MS","doi":"10.23937/2572-3286.1510035","DOIUrl":"https://doi.org/10.23937/2572-3286.1510035","url":null,"abstract":"Purpose: Chronic kidney disease is a public health problem that causes severe complications to the patient. The major damage is the loss of muscle mass, with a consequent reduction in the functional capacity that is associated with hypertension and increased oxidative stress. This study aimed to evaluate the effect of intra-dialysis resistance training on the hemodynamic parameters, oxidative stress and quality of life in patients with chronic kidney disease. Methods: The volunteers underwent a physical training during the hemodialysis sessions. The hemodynamic parameters, oxidative stress, the quality of life, the functional autonomy and one repetition maximum (1 RM) were evaluated. Results: The data did not show alterations in the hemodynamic parameters, nitric oxide or lipid peroxidation after 12 weeks of resistance training. We observed significant differences in the quality of life in the following dimensions of the Kidney Disease Quality of Life Short Form (KDQOL-SFTM) questionnaire after 12 weeks of resistance training: Functional capacity, physical aspects, vitality, social and emotional aspects and mental health (P < 0.05). The time needed to execute the functional autonomy test was improved after the resistance training, and strength was increased significantly in all the exercises, as assessed by the 1 RM test (P < 0.001). Conclusion: In conclusion, after 12 weeks, the intra-dialysis resistance training did not modify the hemodynamic parameters neither the oxidative stress profile of these patients, but improved their quality of life. These data show that intra-dialysis resistance training is safe and can provide many physical and emotional benefits to chronic kidney disease patients.","PeriodicalId":73669,"journal":{"name":"Journal of clinical nephrology and renal care","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41433407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effective Role of CVVH in Fatal Phenobarbital Overdose Clearance: A Case Report CVVH在致死性苯巴比妥超剂量清除中的有效作用:一例报告
Pub Date : 2018-06-30 DOI: 10.23937/2572-3286.1510034
Ebad Chaudhry Adeel, G. Alan, J ConlonPeter
We report affective utilization of continuous veno-venous hemofiltration for removal of phenobarbital in a patient who took twice amount of fatal dose and was hemodynamically stable. Historically treatment includes supportive care, activated charcoal and urinary alkalinisation along with the application of extracorporeal treatments such as charcoal haem perfusion or hemodialysis and continuous veno-venous hemodiafiltration are affective treatment for removal of drug. Early initiation of extracorporeal treatment and increasing blood flow rate effectively reduced half life of drug and improved patient outcome with fatal poisoning. known time. He was brought unconscious had GCS of 3 blood pressure 120/75 pulse 85 per minutes’ respiratory rate 12 per minutes’ and temperature of 36.5 °C was intubated and ventilated and transferred to intensive care unit. His medical background history includes bipolar disorder, deliberate self harm. His initial investigation showed positive blood and urine toxicology screen for barbiturates only and phenobarbital level of 160.5 mg/L, others investigation including full blood count, renal profile, liver function, arterial blood gases, calcium, phosphate, amylase, creatinine kinase and coagulation screen within normal limits (Table 1). His electrocardiogram showed prolonged QT. He remained hemodynamically stable without any inotropic support was started on supportive management with intravenous fluid and activated charcoal in intensive care unit as renal profile and acid base status remained within fair range with no evidence of renal failure. His repeat phenobarbital level after 48 hours was 221.8 mg/L likely due to redistribution of drug.
我们报告持续静脉-静脉血液滤过去除苯巴比妥的有效利用在病人服用两倍的致死剂量和血液动力学稳定。历史上的治疗包括支持治疗,活性炭和尿碱化以及体外治疗的应用,如木炭血红素灌注或血液透析和持续的静脉-静脉血液透析滤过是去除药物的有效治疗。尽早开始体外治疗和增加血流量可有效缩短药物半衰期,改善致死性中毒患者的预后。已知的时间。患者昏迷,GCS 3,血压120/75,脉搏85 /分钟,呼吸频率12 /分钟,体温36.5°C,插管通气,转重症监护病房。他的病史包括躁郁症,故意自残。他的初步调查显示血液和尿液毒理学筛查阳性,仅巴比妥类药物和苯巴比妥水平为160.5 mg/L,其他调查包括全血细胞计数、肾谱、肝功能、动脉血气、钙、磷酸盐、淀粉酶、他的心电图显示QT间期延长,在没有任何肌力支持的情况下,他的血流动力学保持稳定,在重症监护病房开始静脉输液和活性炭的支持管理,因为肾脏特征和酸碱状态保持在合理范围内,没有肾衰竭的迹象。48小时后重复苯巴比妥水平为221.8 mg/L,可能与药物重新分配有关。
{"title":"Effective Role of CVVH in Fatal Phenobarbital Overdose Clearance: A Case Report","authors":"Ebad Chaudhry Adeel, G. Alan, J ConlonPeter","doi":"10.23937/2572-3286.1510034","DOIUrl":"https://doi.org/10.23937/2572-3286.1510034","url":null,"abstract":"We report affective utilization of continuous veno-venous hemofiltration for removal of phenobarbital in a patient who took twice amount of fatal dose and was hemodynamically stable. Historically treatment includes supportive care, activated charcoal and urinary alkalinisation along with the application of extracorporeal treatments such as charcoal haem perfusion or hemodialysis and continuous veno-venous hemodiafiltration are affective treatment for removal of drug. Early initiation of extracorporeal treatment and increasing blood flow rate effectively reduced half life of drug and improved patient outcome with fatal poisoning. known time. He was brought unconscious had GCS of 3 blood pressure 120/75 pulse 85 per minutes’ respiratory rate 12 per minutes’ and temperature of 36.5 °C was intubated and ventilated and transferred to intensive care unit. His medical background history includes bipolar disorder, deliberate self harm. His initial investigation showed positive blood and urine toxicology screen for barbiturates only and phenobarbital level of 160.5 mg/L, others investigation including full blood count, renal profile, liver function, arterial blood gases, calcium, phosphate, amylase, creatinine kinase and coagulation screen within normal limits (Table 1). His electrocardiogram showed prolonged QT. He remained hemodynamically stable without any inotropic support was started on supportive management with intravenous fluid and activated charcoal in intensive care unit as renal profile and acid base status remained within fair range with no evidence of renal failure. His repeat phenobarbital level after 48 hours was 221.8 mg/L likely due to redistribution of drug.","PeriodicalId":73669,"journal":{"name":"Journal of clinical nephrology and renal care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47232105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Chronic Kidney Disease on a Physical Activity Intervention: Impact on Physical Function, Adherence, and Safety. 慢性肾病对体育锻炼干预的影响:对身体功能、坚持性和安全性的影响
Pub Date : 2017-01-01 Epub Date: 2017-02-14 DOI: 10.23937/2572-3286.1510021
C K Liu, J Milton, F-C Hsu, K M Beavers, V Yank, T Church, J D Shegog, S Kashaf, S Nayfield, A Newman, R S Stafford, B Nicklas, D E Weiner, R A Fielding

Background: Because chronic kidney disease (CKD) is associated with muscle wasting, older adults with CKD are likely to have physical function deficits. Physical activity can improve these deficits, but whether CKD attenuates the benefits is unknown. Our objective was to determine if CKD modified the effect of a physical activity intervention in older adults.

Methods: This is an exploratory analysis of the LIFE-P study, which compared a 12-month physical activity program (PA) to a successful aging education program (SA) in older adults. CKD was defined as a baseline eGFR < 60 mL/min/1.73 m2. We examined the Short Physical Performance Battery (SPPB) at baseline, 6 and 12 months. Secondary outcomes included serious adverse events (SAE) and adherence to intervention frequency. Linear mixed models were adjusted for age, sex, diabetes, hypertension, CKD, intervention, site, visit, baseline SPPB, and interactions of intervention and visit and of intervention, visit, and baseline CKD.

Results: The sample included 368 participants. CKD was present in 105 (28.5%) participants with a mean eGFR of 49.2 ± 8.1 mL/min/1.73 m2. Mean SPPB was 7.38 ± 1.41 in CKD participants; 7.59 ± 1.44 in those without CKD (p = 0.20). For CKD participants in PA, 12-month SPPBs increased to 8.90 (95% CI 8.32, 9.47), while PA participants without CKD increased to 8.40 (95% CI 8.01, 8.79, p = 0.43). For CKD participants in SA, 12-month SPPBs increased to 7.67 (95% CI 7.07, 8.27), while participants without CKD increased to 8.12 (95% CI 7.72, 8.52, p = 0.86). Interaction between CKD and intervention was non-significant (p = 0.88). Number and type of SAEs were not different between CKD and non-CKD participants (all p > 0.05). In PA, adherence for CKD participants was 65.5 ± 25.4%, while for those without CKD was 74.0 ± 22.2% (p = 0.12).

Conclusion: Despite lower adherence, older adults with CKD likely derive clinically meaningful benefits from physical activity with no apparent impact on safety, compared to those without CKD.

背景:由于慢性肾脏病(CKD)与肌肉萎缩有关,患有慢性肾脏病的老年人很可能存在身体功能缺陷。体育锻炼可以改善这些缺陷,但 CKD 是否会削弱体育锻炼的益处尚不清楚。我们的目标是确定慢性肾功能衰竭是否会改变老年人体育锻炼干预的效果:本研究是对 LIFE-P 研究的探索性分析,该研究比较了老年人为期 12 个月的体育锻炼计划(PA)和成功的老龄化教育计划(SA)。慢性肾功能衰竭的定义是基线 eGFR < 60 mL/min/1.73 m2。我们对基线、6 个月和 12 个月的短期体能测试(SPPB)进行了检查。次要结果包括严重不良事件(SAE)和坚持干预频率。线性混合模型对年龄、性别、糖尿病、高血压、慢性肾脏病、干预、地点、就诊、基线 SPPB 以及干预与就诊的交互作用和干预、就诊与慢性肾脏病基线的交互作用进行了调整:样本包括 368 名参与者。其中 105 人(28.5%)患有慢性肾脏病,平均 eGFR 为 49.2 ± 8.1 mL/min/1.73 m2。患有慢性肾功能衰竭的参与者的平均 SPPB 为 7.38 ± 1.41;未患有慢性肾功能衰竭的参与者的平均 SPPB 为 7.59 ± 1.44(p = 0.20)。对于 PA 的 CKD 患者,12 个月 SPPB 上升至 8.90(95% CI 8.32,9.47),而 PA 的非 CKD 患者则上升至 8.40(95% CI 8.01,8.79,p = 0.43)。对于参加 SA 的 CKD 参与者,12 个月 SPPBs 上升至 7.67(95% CI 7.07,8.27),而未参加 CKD 的参与者则上升至 8.12(95% CI 7.72,8.52,p = 0.86)。慢性肾脏病与干预之间的交互作用不显著(p = 0.88)。慢性阻塞性肺病和非慢性阻塞性肺病参与者的 SAE 数量和类型没有差异(所有 p > 0.05)。在 PA 中,CKD 参与者的依从性为 65.5 ± 25.4%,而非 CKD 参与者的依从性为 74.0 ± 22.2%(p = 0.12):尽管坚持体育锻炼的比例较低,但与未患慢性肾脏病的老年人相比,患有慢性肾脏病的老年人可能会从体育锻炼中获得有临床意义的益处,而且对安全性没有明显影响。
{"title":"The Effect of Chronic Kidney Disease on a Physical Activity Intervention: Impact on Physical Function, Adherence, and Safety.","authors":"C K Liu, J Milton, F-C Hsu, K M Beavers, V Yank, T Church, J D Shegog, S Kashaf, S Nayfield, A Newman, R S Stafford, B Nicklas, D E Weiner, R A Fielding","doi":"10.23937/2572-3286.1510021","DOIUrl":"10.23937/2572-3286.1510021","url":null,"abstract":"<p><strong>Background: </strong>Because chronic kidney disease (CKD) is associated with muscle wasting, older adults with CKD are likely to have physical function deficits. Physical activity can improve these deficits, but whether CKD attenuates the benefits is unknown. Our objective was to determine if CKD modified the effect of a physical activity intervention in older adults.</p><p><strong>Methods: </strong>This is an exploratory analysis of the LIFE-P study, which compared a 12-month physical activity program (PA) to a successful aging education program (SA) in older adults. CKD was defined as a baseline eGFR < 60 mL/min/1.73 m<sup>2</sup>. We examined the Short Physical Performance Battery (SPPB) at baseline, 6 and 12 months. Secondary outcomes included serious adverse events (SAE) and adherence to intervention frequency. Linear mixed models were adjusted for age, sex, diabetes, hypertension, CKD, intervention, site, visit, baseline SPPB, and interactions of intervention and visit and of intervention, visit, and baseline CKD.</p><p><strong>Results: </strong>The sample included 368 participants. CKD was present in 105 (28.5%) participants with a mean eGFR of 49.2 ± 8.1 mL/min/1.73 m<sup>2</sup>. Mean SPPB was 7.38 ± 1.41 in CKD participants; 7.59 ± 1.44 in those without CKD (p = 0.20). For CKD participants in PA, 12-month SPPBs increased to 8.90 (95% CI 8.32, 9.47), while PA participants without CKD increased to 8.40 (95% CI 8.01, 8.79, p = 0.43). For CKD participants in SA, 12-month SPPBs increased to 7.67 (95% CI 7.07, 8.27), while participants without CKD increased to 8.12 (95% CI 7.72, 8.52, p = 0.86). Interaction between CKD and intervention was non-significant (p = 0.88). Number and type of SAEs were not different between CKD and non-CKD participants (all p > 0.05). In PA, adherence for CKD participants was 65.5 ± 25.4%, while for those without CKD was 74.0 ± 22.2% (p = 0.12).</p><p><strong>Conclusion: </strong>Despite lower adherence, older adults with CKD likely derive clinically meaningful benefits from physical activity with no apparent impact on safety, compared to those without CKD.</p>","PeriodicalId":73669,"journal":{"name":"Journal of clinical nephrology and renal care","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10056048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of clinical nephrology and renal care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1